Recent Finacing
Recent Raise
Acesion Pharma is a Copenhagen biotech developing SK ion channel inhibitors for atrial fibrillation, with AP30663 (IV conversion; completed Phase 2) and AP31969 (oral maintenance entering Phase 1/Phase 2).
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Acesion Pharma.
